Efficacy of T2259 in DED

A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye

NCT02975102 ·Status: COMPLETED ·Phase: NA

Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness

NCT03645850 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome

NCT00788229 ·Status: COMPLETED ·Phase: PHASE2

Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.

NCT01155999 ·Status: COMPLETED ·Phase: PHASE3

Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye

NCT03815539 ·Status: UNKNOWN ·Phase: NA

To Demonstrate the Non-inferiority of Eyestil Protection® Compared to Vismed® in Terms of Clinical Performance

NCT03803722 ·Status: TERMINATED ·Phase: NA

Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease

NCT05865379 ·Status: RECRUITING ·Phase: NA

Evaluation of Optical System in the Treatment of - Dry Eye Disease

NCT05741398 ·Status: UNKNOWN ·Phase: NA

Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

NCT06375499 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Performance and Safety of CBL-102 Versus Vismed® Multi Eye Drops in the Management of Dry Eye

NCT03368404 ·Status: COMPLETED ·Phase: NA

Evaluation of MAF-1217 in Patients With DED

NCT03833882 ·Status: COMPLETED ·Phase: NA

3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

NCT04685109 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction

NCT02958514 ·Status: COMPLETED ·Phase: NA

Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease

NCT06615453 ·Status: RECRUITING ·Phase: NA

TearCare System to Treat Dry Eye Disease

NCT03857919 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome

NCT00599716 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).

NCT07264517 ·Status: RECRUITING ·Phase: PHASE2

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

NCT06625398 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

NCT04701086 ·Status: COMPLETED ·Phase: NA

Evaluation of the Corneal Endothelial Cell Layer by Specular Microscopy in Patients With Thyroid Eye Disease

NCT06235372 ·Status: NOT_YET_RECRUITING

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

NCT06625411 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Impairment of Reading Ability in Dry Eye Patients

NCT01826812 ·Status: COMPLETED

Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease

NCT04313725 ·Status: TERMINATED ·Phase: NA

Evaluation of BTV100 in Subjects With Dry Eye Disease

NCT06543303 ·Status: RECRUITING ·Phase: PHASE2

OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)

NCT05814757 ·Status: COMPLETED ·Phase: PHASE2